Search
healthcare › clinical-trials › h-46124
… of this study is to determine if the investigational combination of avelumab with several different drugs - … PF-04518600 or binimetinib - is safe and effective for treating patients with metastatic triple-negative breast … TBCRC 047: Innovative Combination Immunotherapy for Metastatic Triple-Negative …
news › baylor-and-leica-biosystems-team-up-for-digital-pathology-global-services
… has teamed with Leica Biosystems , a cancer diagnostics company and global leader in workflow solutions, to launch … innovative new approaches to diagnose and treat disease for delivery of the highest quality healthcare," said Dr. … with a focus on education, healthcare, research and community outreach. With more than 90 board-certified …
healthcare › clinical-trials › h-44518
… this observational registry study is to gather information from multiple clinical sites about patients with Parkinson's …
healthcare › clinical-trials › h-7543
… The purpose of this study is to provide genetic information and materials for future research on disorders such as Parkinson's … Collection of Clinical Data and DNA/RNA Samples for Neurodegenerative Disorders …
healthcare › clinical-trials › h-49809
… free, scientifically-backed, parent-based treatment program for anxiety and OCD in children and adolescents. This … involved? A free, 12-week course of parent-based therapy for children with anxiety or OCD with sessions delivered via … Is this study right for me? Can your child communicate verbally? Do you and your child speak English? …
news › a-machine-learning-approach-and-blood-test-for-predicting-risk-of-schizophrenia
… strategy that analyzes specific regions of the genome offers the possibility of early diagnosis of schizophrenia, … the different cells in the body which genes to turn on or off in that cell type, therefore epigenetic markers can vary …
news › dr-hyun-sung-lee-awarded-funding-for-checkpoint-immuno-therapy-study
… (MHC Class I Chain-Related Protein) antibody in overcoming resistance to checkpoint immunotherapy by targeting … approach. This investigation will lay a solid foundation for future clinical trials. This year Dr. Lee has launched … through the integration of state-of-the-art single-cell platforms and inform the design of novel approaches to …
news › graduates-encouraged-to-hold-firm-to-values
… was held Tuesday, May 28, at Jesse H. Jones Hall for the Performing Arts in downtown Houston, marking the graduation of … them during their Baylor training. “You have been prepared for your careers based on our mission, vision and, most … Graduates inspired to hold firm to values, build future for all …
healthcare › clinical-trials › h-42434
… to pancreatic cancer patients as adjuvant therapy following completion of standard chemotherapy. Patients will first complete standard treatment for pancreatic adenocarcinoma which is surgically resectable … Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma …
news › baylor-recruiting-for-study-to-observe-covid-19-in-cancer-patients
… Medicine is currently recruiting cancer patients in Houston for the study. Researchers will collect clinical data, … how COVID-19 impacts the course of cancer treatment and outcomes. “We are looking to see if cancer type, treatment type or demographic factors may contribute to different outcomes for COVID-19,” said Dr. Claire Hoppenot , co-principal …